Literature DB >> 10212101

Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis.

S Nava1, F Rubini.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis is an inflammatory disease which leads to chronic ventilatory insufficiency and is characterised by a reduction in pulmonary static and dynamic volumes. It has been suggested that lung elastance may also be abnormally increased, particularly in end stage disease, but this has not been systematically tested. The aim of this study was to assess the respiratory mechanics during mechanical ventilation in patients affected by end stage disease.
METHODS: Respiratory mechanics were monitored in seven patients with idiopathic pulmonary fibrosis being ventilated for acute respiratory failure (PaO2/FiO2 5.8 (0.3); pH 7. 28 (0.02); PaCO2 8.44 (0.82) kPa; tidal volume 3.4 (0.2) ml/kg; respiratory rate 35.1 (8.8) breaths/min) using an oesophageal balloon and airway occlusion during constant flow inflation. The total respiratory system mechanics (rs) was partitioned into lung (L) and chest wall (w) mechanics to measure static intrinsic positive end expiratory pressure (PEEPi), static (Est) and dynamic (Edyn) elastances, total respiratory resistance (Rrs), interrupter respiratory resistance (Rint,rs), and additional respiratory resistance (DeltaRrs).
RESULTS: PEEPi was negligible in all patients. Edyn,rs and Est,rs were markedly increased (60.9 (7.3) and 51.9 (8. 0) cm H2O/l, respectively), and this was due to abnormal lung elastance (dynamic 53.9 (8.0) cm H2O/l, static 46.1 (8.1) cm H2O/l) while chest wall elastance was only slightly increased. Rrs and Rint, rs were also increased above the normal range (16.7 (4.5) and 13.7 (3.5) cm H2O/l/s, respectively). RL and Rint,L contributed 88% and 89%, on average, to the total. Edyn,rs, Est,rs, Rrs and Rint,rs were significantly correlated with the degree of hypercapnia (r = 0.64 (p<0.01), r = 0.54 (p<0.05), r = 0.84 (p<0.001), and r = 0.72 (p<0. 001), respectively).
CONCLUSIONS: The elastances and resistances of the respiratory system are significantly altered in ventilated patients with end stage idiopathic pulmonary fibrosis. These features are almost totally due to abnormalities in lung mechanics. These profound alterations in elastic and resistive mechanical properties at this stage of the disease may be responsible for the onset of hypercapnia.

Entities:  

Mesh:

Year:  1999        PMID: 10212101      PMCID: PMC1763791          DOI: 10.1136/thx.54.5.390

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  24 in total

1.  Value of static pulmonary compliance in predicting mortality in patients with acute respiratory failure.

Authors:  J Mancebo; S Benito; M Martín; A Net
Journal:  Intensive Care Med       Date:  1988       Impact factor: 17.440

2.  Pulmonary and chest wall mechanics in anesthetized paralyzed humans.

Authors:  E D'Angelo; F M Robatto; E Calderini; M Tavola; D Bono; G Torri; J Milic-Emili
Journal:  J Appl Physiol (1985)       Date:  1991-06

3.  Respiratory mechanics in anesthetized paralyzed humans: effects of flow, volume, and time.

Authors:  E D'Angelo; E Calderini; G Torri; F M Robatto; D Bono; J Milic-Emili
Journal:  J Appl Physiol (1985)       Date:  1989-12

4.  Flow and volume dependence of pulmonary mechanics in anesthetized cats.

Authors:  T Kochi; S Okubo; W A Zin; J Milic-Emili
Journal:  J Appl Physiol (1985)       Date:  1988-01

5.  Respiratory mechanics during the first day of mechanical ventilation in patients with pulmonary edema and chronic airway obstruction.

Authors:  C Broseghini; R Brandolese; R Poggi; G Polese; E Manzin; J Milic-Emili; A Rossi
Journal:  Am Rev Respir Dis       Date:  1988-08

6.  Respiratory mechanics during halothane anesthesia and anesthesia-paralysis in humans.

Authors:  P K Behrakis; B D Higgs; A Baydur; W A Zin; J Milic-Emili
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1983-10

7.  A simple method for assessing the validity of the esophageal balloon technique.

Authors:  A Baydur; P K Behrakis; W A Zin; M Jaeger; J Milic-Emili
Journal:  Am Rev Respir Dis       Date:  1982-11

8.  Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis.

Authors:  R M Rudd; P L Haslam; M Turner-Warwick
Journal:  Am Rev Respir Dis       Date:  1981-07

9.  Morphologic-physiologic correlates of the severity of fibrosis and degree of cellularity in idiopathic pulmonary fibrosis.

Authors:  J D Fulmer; W C Roberts; E R von Gal; R G Crystal
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

10.  Diffuse interstitial pneumonitis. Clinicopathologic correlations in 20 patients treated with prednisone/azathioprine.

Authors:  R H Winterbauer; S P Hammar; K O Hallman; J E Hays; N E Pardee; E H Morgan; J D Allen; K D Moores; W Bush; J H Walker
Journal:  Am J Med       Date:  1978-10       Impact factor: 4.965

View more
  29 in total

1.  Ventilator settings and outcome of respiratory failure in chronic interstitial lung disease.

Authors:  Evans R Fernández-Pérez; Murat Yilmaz; Hussam Jenad; Craig E Daniels; Jay H Ryu; Rolf D Hubmayr; Ognjen Gajic
Journal:  Chest       Date:  2007-11-07       Impact factor: 9.410

2.  Automated quantification of lung structures from optical coherence tomography images.

Authors:  Alex M Pagnozzi; Rodney W Kirk; Brendan F Kennedy; David D Sampson; Robert A McLaughlin
Journal:  Biomed Opt Express       Date:  2013-10-09       Impact factor: 3.732

3.  An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.

Authors:  Ganesh Raghu; Harold R Collard; Jim J Egan; Fernando J Martinez; Juergen Behr; Kevin K Brown; Thomas V Colby; Jean-François Cordier; Kevin R Flaherty; Joseph A Lasky; David A Lynch; Jay H Ryu; Jeffrey J Swigris; Athol U Wells; Julio Ancochea; Demosthenes Bouros; Carlos Carvalho; Ulrich Costabel; Masahito Ebina; David M Hansell; Takeshi Johkoh; Dong Soon Kim; Talmadge E King; Yasuhiro Kondoh; Jeffrey Myers; Nestor L Müller; Andrew G Nicholson; Luca Richeldi; Moisés Selman; Rosalind F Dudden; Barbara S Griss; Shandra L Protzko; Holger J Schünemann
Journal:  Am J Respir Crit Care Med       Date:  2011-03-15       Impact factor: 21.405

Review 4.  Pulmonary function testing in idiopathic interstitial pneumonias.

Authors:  Fernando J Martinez; Kevin Flaherty
Journal:  Proc Am Thorac Soc       Date:  2006-06

Review 5.  Preoperative physiotherapy in subjects with idiopathic pulmonary fibrosis qualified for lung transplantation: implications on hospital length of stay and clinical outcomes.

Authors:  Massimiliano Polastri; Andrea Dell'Amore; Giulia Zagnoni; Stefano Nava
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

Review 6.  Acute exacerbation of idiopathic pulmonary fibrosis-a review of current and novel pharmacotherapies.

Authors:  Maya M Juarez; Andrew L Chan; Andrew G Norris; Brian M Morrissey; Timothy E Albertson
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

7.  β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix.

Authors:  Alysia Kern Lovgren; Jeffrey J Kovacs; Ting Xie; Erin N Potts; Yuejuan Li; W Michael Foster; Jiurong Liang; Eric B Meltzer; Dianhua Jiang; Robert J Lefkowitz; Paul W Noble
Journal:  Sci Transl Med       Date:  2011-03-16       Impact factor: 17.956

8.  Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis.

Authors:  Arturo Cortes-Telles; Lutz Forkert; Denis E O'Donnell; Onofre Moran-Mendoza
Journal:  Can Respir J       Date:  2014-04-07       Impact factor: 2.409

Review 9.  Lung parenchymal mechanics.

Authors:  Béla Suki; Dimitrije Stamenović; Rolf Hubmayr
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

10.  Fructose-1,6-Bisphosphate Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice and Inhibits the Proliferation of Lung Fibroblasts.

Authors:  Renan Trevisan Jost; Henrique Bregolin Dias; Gabriele Catyana Krause; Rodrigo Godinho de Souza; Tássia Rezende de Souza; Nailê Karine Nuñez; Fernanda Greinert Dos Santos; Gabriela Viegas Haute; Denizar Alberto da Silva Melo; Paulo Márcio Pitrez; Vinicius Duval da Silva; Márcio Vinícius Fagundes Donadio; Jarbas Rodrigues de Oliveira
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.